Ostrich antibodies for bacterial infections
JP7740725B2Active Publication Date: 2025-09-17OSTRICH PHARMA KK
Patent Information
- Application Number
- JP2023124345
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-11-02
- Filing Date
- 2023-07-31
- Publication Date
- 2025-09-17
- Estimated Expiration
- 2038-11-01
Smart Images

Figure 0007740725000005 
Figure 0007740725000006 
Figure 0007740725000007
Abstract
To provide an ostrich antibody-containing composition for treating a bacterial infectious disease, and a method for treating a bacterial infectious disease by using the ostrich antibody.SOLUTION: The present invention further provides a method for producing such an ostrich antibody. The infectious disease can be a gastrointestinal infection. The ostrich antibody can be produced by using a bacterium-derived component as an immunogen. The bacterium can be Clostridium difficile, Vibrio cholera, Staphylococcus aureus, or the like. Furthermore, the bacterium can be a drug-resistant bacterium.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Human polyclonal antibody composition
JP2002316944A
Human antibodies against Staphylococcus aureus
JP2003503015A
Staphylococcus aureus-specific human recombinant polyclonal antibody and its use
JP2013538573A
Antiglucosaminidase passive immunization for Staphylococcus aureus infections
JP2015505815A
Ostrich yellow egg antibody-containing candy production method and ostrich yellow egg antibody-containing candy
JP2017184669A